BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wan W, Liu G, Li X, Liu Y, Wang Y, Pan H, Hu J. MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease. Bioengineered 2021;12:12678-90. [PMID: 34818971 DOI: 10.1080/21655979.2021.2008638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Shui X, Zhang M, Mei Y, Xia Y, Lan G, Hu L, Gan CL, Tian Y, Li R, Gu X, Zhang T, Chen D, Lee TH. MiR-191-5p Attenuates Tau Phosphorylation, Aβ Generation, and Neuronal Cell Death by Regulating Death-Associated Protein Kinase 1. ACS Chem Neurosci 2022;13:3554-66. [PMID: 36454178 DOI: 10.1021/acschemneuro.2c00423] [Reference Citation Analysis]
2 Ma Y, Huang S, Jiang H, Yang W. Mechanism of Zhinao Capsule in Treating Alzheimer’s Disease Based on Network Pharmacology Analysis and Molecular Docking Validation. Journal of Healthcare Engineering 2022;2022:1-12. [DOI: 10.1155/2022/5708769] [Reference Citation Analysis]
3 Harrell CR, Volarevic V, Djonov V, Volarevic A. Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases. Int J Mol Sci 2022;23:4487. [PMID: 35562878 DOI: 10.3390/ijms23094487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]